JP2003514518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003514518A5 JP2003514518A5 JP2001535575A JP2001535575A JP2003514518A5 JP 2003514518 A5 JP2003514518 A5 JP 2003514518A5 JP 2001535575 A JP2001535575 A JP 2001535575A JP 2001535575 A JP2001535575 A JP 2001535575A JP 2003514518 A5 JP2003514518 A5 JP 2003514518A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- component
- recombinant fusion
- protein according
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9925966.5 | 1999-11-02 | ||
| GBGB9925966.5A GB9925966D0 (en) | 1999-11-02 | 1999-11-02 | Threapeutic vaccines against variable viruses and other targets |
| PCT/GB2000/004191 WO2001032893A1 (en) | 1999-11-02 | 2000-11-01 | Recombinant therapeutic fusion proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003514518A JP2003514518A (ja) | 2003-04-22 |
| JP2003514518A5 true JP2003514518A5 (enExample) | 2007-12-20 |
| JP4768944B2 JP4768944B2 (ja) | 2011-09-07 |
Family
ID=10863838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001535575A Expired - Fee Related JP4768944B2 (ja) | 1999-11-02 | 2000-11-01 | 組換え型の治療的融合タンパク |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7390881B2 (enExample) |
| EP (1) | EP1226256B1 (enExample) |
| JP (1) | JP4768944B2 (enExample) |
| AT (1) | ATE358727T1 (enExample) |
| AU (1) | AU1156001A (enExample) |
| CA (1) | CA2389339A1 (enExample) |
| DE (1) | DE60034243T2 (enExample) |
| ES (1) | ES2284537T3 (enExample) |
| GB (1) | GB9925966D0 (enExample) |
| HK (1) | HK1048335B (enExample) |
| WO (1) | WO2001032893A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8029803B2 (en) | 2002-06-20 | 2011-10-04 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
| US8007805B2 (en) * | 2003-08-08 | 2011-08-30 | Paladin Labs, Inc. | Chimeric antigens for breaking host tolerance to foreign antigens |
| CA2538887A1 (en) * | 2003-09-15 | 2005-03-31 | Id Biomedical Corporation Of Quebec | Measles subunit vaccine |
| WO2006133497A1 (en) * | 2005-06-15 | 2006-12-21 | Adelaide Research & Innovation Pty Ltd | Combination treatment |
| ES2337113B1 (es) * | 2007-04-17 | 2011-01-24 | Centre De Recerca En Sanitat Animal (Cresa) | Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993021325A1 (en) * | 1992-04-08 | 1993-10-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| ATE288488T1 (de) * | 1997-03-11 | 2005-02-15 | Mayo Foundation | Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen |
| ATE441435T1 (de) | 1998-06-11 | 2009-09-15 | Us Gov Health & Human Serv | Gegen hiv-1 gp120 envelope glykoprotein gerichtete rekombinant-immunotoxin |
| DE60040136D1 (de) | 1999-03-16 | 2008-10-16 | Us Gov Nat Inst Health | Ein neues chimäres protein für die prävention und die behandlung einer hiv infektion |
-
1999
- 1999-11-02 GB GBGB9925966.5A patent/GB9925966D0/en not_active Ceased
-
2000
- 2000-11-01 AU AU11560/01A patent/AU1156001A/en not_active Abandoned
- 2000-11-01 WO PCT/GB2000/004191 patent/WO2001032893A1/en not_active Ceased
- 2000-11-01 DE DE60034243T patent/DE60034243T2/de not_active Expired - Lifetime
- 2000-11-01 AT AT00973003T patent/ATE358727T1/de not_active IP Right Cessation
- 2000-11-01 EP EP00973003A patent/EP1226256B1/en not_active Expired - Lifetime
- 2000-11-01 CA CA002389339A patent/CA2389339A1/en not_active Abandoned
- 2000-11-01 HK HK03100373.4A patent/HK1048335B/en not_active IP Right Cessation
- 2000-11-01 ES ES00973003T patent/ES2284537T3/es not_active Expired - Lifetime
- 2000-11-01 JP JP2001535575A patent/JP4768944B2/ja not_active Expired - Fee Related
-
2005
- 2005-05-09 US US11/124,971 patent/US7390881B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100715954B1 (ko) | 펩티드 리간드에 의하여 부착된 다중 면역원성 성분을보유한 ｈｂｖ 코어 항원 입자 | |
| JP4713809B2 (ja) | Ｂ型肝炎コア抗原融合タンパク質 | |
| EP3094644B1 (en) | Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen | |
| CA2347411A1 (en) | Virus-like particles for the induction of autoantibodies | |
| KR960703136A (ko) | 탠덤 합성 hiv-1 펩티드들 | |
| NO20025153D0 (no) | FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1 | |
| JP2012501959A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| JPH0327400A (ja) | Ｂ型肝炎ウイルスコア抗原粒子 | |
| Koletzki et al. | Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles | |
| Hu et al. | A flexible peptide linker enhances the immunoreactivity of two copies HBsAg preS1 (21–47) fusion protein | |
| JP2003514518A5 (enExample) | ||
| Hu et al. | Expression of overlapping PreS1 fragment recombinant proteins for the determination of immunogenic domains in HBsAg PreS1 region | |
| JP2003514576A5 (enExample) | ||
| Manivel et al. | A synthetic peptide spontaneously self-assembles to reconstruct a group-specific, conformational determinant of hepatitis B surface antigen. | |
| Park et al. | Determination of the protective effects of neutralizing anti‐hepatitis B virus (HBV) immunoglobulins by epitope mapping with recombinant HBV surface‐antigen proteins | |
| Park et al. | Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope | |
| CN102464721A (zh) | 针对人肠道病毒71型的重组广谱性疫苗 | |
| US20040106174A1 (en) | Designing immunogens | |
| thi Man et al. | Structural relationships between hepatitis B surface antigen in human plasma and dimers from recombinant vaccine: a monoclonal antibody study | |
| JP2001503750A (ja) | Ｂ型肝炎インヒビター | |
| JPS58150518A (ja) | Ｂ型肝炎ウイルスのための免疫学的組成物及び方法 | |
| Pillot et al. | Immunochemical structure of the hepatitis B surface antigen vaccine—I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting | |
| GB9925966D0 (en) | Threapeutic vaccines against variable viruses and other targets | |
| JP2001517447A5 (enExample) |